Jonaitis, L., Marković, S., Farkas, K., Gheorghe, L., Krznarić, Ž., Salupere, R. ... Drobne, D. (2021). Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective. BMC Proceedings, 15. (S17). doi: 10.1186/s12919-021-00230-7
Jonaitis, Laimas, et al. "Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective." BMC Proceedings, vol. 15, no. S17, 2021. https://doi.org/10.1186/s12919-021-00230-7
Jonaitis, Laimas, Srdjan Marković, Klaudia Farkas, Liana Gheorghe, Željko Krznarić, Riina Salupere, Viktorija Mokricka, et al. "Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective." BMC Proceedings 15, no. S17 (2021). https://doi.org/10.1186/s12919-021-00230-7
Jonaitis, L., et al. (2021) 'Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective', BMC Proceedings, 15(S17). doi: 10.1186/s12919-021-00230-7
Jonaitis L, Marković S, Farkas K, Gheorghe L, Krznarić Ž, Salupere R, and sur.. Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective. BMC Proceedings [Internet]. 2021 December 09 [cited 2024 August 21];15(S17). doi: 10.1186/s12919-021-00230-7
L. Jonaitis, et al., "Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective", BMC Proceedings, vol. 15, no. S17, December 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:568661. [Accessed: 21 August 2024]